Jiuzhitang Co., Ltd. 2025 Internal Control Self-Assessment Report

Log in to the Sina Finance app and search for 【information disclosure】 to view more assessment grades

Stock code: 000989 Stock abbreviation: Jiuzhitang (rights protection) Announcement No.: 2026-017

Jiuzhitang Co., Ltd.

2025 Internal Control Self-Assessment Report

Our company and all members of the board of directors warrant that the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

In accordance with the provisions of the 《Basic Norms for Enterprise Internal Control》 and its supporting guidelines, and other requirements for internal control regulatory supervision (hereinafter referred to as the enterprise internal control standards system), together with our company’s (hereinafter referred to as the “Company”) internal control policies and assessment measures, based on daily internal control supervision and special supervision, we evaluated the effectiveness of the Company’s internal control as of December 31, 2025 (the benchmark date for the internal control assessment report).

I. Important Statements

Pursuant to the provisions of the enterprise internal control standards system, it is the responsibility of the board of directors of the Company to establish, improve, and effectively implement internal control, assess its effectiveness, and truthfully disclose the internal control assessment report. The Audit Committee supervises the board of directors’ establishment and implementation of internal control. The management team is responsible for organizing and leading the Company’s daily operation of internal control. The board of directors, the Audit Committee, the directors, and senior management members of the Company ensure that there are no false records, misleading statements, or material omissions in the contents of this report, and assume individual and joint legal liability for the truthfulness, accuracy, and completeness of the report contents.

The objective of the Company’s internal control is to reasonably ensure lawful and compliant operation and management, asset safety, the truthfulness and completeness of financial reporting and related information, improve operating efficiency and effectiveness, and promote the realization of development strategies. Due to the inherent limitations of internal control, it can only provide reasonable assurance for achieving the above objectives. In addition, due to changes in circumstances, internal control may become inappropriate, or the degree of adherence to control policies and procedures may decline; therefore, based on the results of the internal control assessment, there is a certain risk in inferring the future effectiveness of internal control.

II. Internal Control Assessment Conclusion

Based on the identification of material defects in internal control over financial reporting, as of the benchmark date of the internal control assessment report, there are no material defects in internal control over financial reporting. The board of directors believes that the Company has maintained effective internal control over financial reporting in all material respects in accordance with the enterprise internal control standards system and relevant requirements.

Based on the identification of material defects in internal control over non-financial reporting, as of the benchmark date of the internal control assessment report, the Company has not found any material defects in internal control over non-financial reporting.

From the benchmark date of the internal control assessment report to the date the internal control assessment report is issued, no factors occurred that would affect the assessment conclusion on the effectiveness of internal control.

III. Internal Control Assessment Work

(I) Scope of Internal Control Assessment

The Company determines the main units, business activities, and matters to be included in the assessment scope, as well as high-risk areas, using a risk-oriented approach. The main units included in this assessment scope include the Company and its wholly-owned and controlled subsidiaries. The total assets of units included in the assessment scope account for 85.69% of the total assets in the Company’s consolidated financial statements. The operating revenue of units included in the assessment scope accounts for 89.24% of the operating revenue in the Company’s consolidated financial statements. The main business activities and matters included in the assessment scope include: organizational structure, development strategy, human resources, social responsibility, fund management, procurement business, production management, asset management, sales management, contract management, research and development, engineering project management, investment management, external guarantees, financial reporting, internal supervision, subsidiary management, related-party transactions, information disclosure, etc.

The above units, business activities, and matters included in the assessment scope cover the major aspects of the Company’s business and management, and there are no material omissions.

(II) Assessment Basis and Standards for Identifying Internal Control Defects

The Company conducts its internal control assessment work based on requirements of the enterprise internal control standards system, including the 《Basic Norms for Enterprise Internal Control》, the 《Enterprise Internal Control Supporting Guidelines》, and the 《Self-Regulatory Guidelines No. 1 for Listed Companies on the Shenzhen Stock Exchange — Standardized Operation of Main Board Listed Companies》, among others.

The board of directors, based on the enterprise internal control standards system’s requirements for identifying major defects, important defects, and general defects, and considering factors such as the Company’s size, industry characteristics, risk appetite, and risk tolerance, distinguishes between internal control over financial reporting and internal control over non-financial reporting. It studies and determines the standards for identifying internal control defects applicable to the Company, and maintains consistency with previous years. The internal control defect identification standards determined by the Company are as follows:

1. Standards for identifying defects in internal control over financial reporting

(1) Quantitative standards for assessing defects in internal control over financial reporting determined by the Company are as follows:

Major defects: The overall impact level of the defect reaches 5% or more of the total profit.

Important defects: The overall impact level of the defect is between 3% (inclusive) and 5% of the total profit.

General defects: The overall impact level of the defect is less than 3% of the total profit.

(2) Qualitative standards for assessing defects in internal control over financial reporting determined by the Company are as follows:

Major defects: A combination of one or more control defects results in an inability to timely prevent or detect and correct material misstatements in the financial reporting. The following situations are identified as major defects:

(a) Fraud by directors and senior executives of the Company that causes significant losses and adverse impacts to the enterprise;

(b) When external auditors discover a material misstatement in the financial report of the current period, and the Company fails to identify it first;

© Material defects that have been identified and reported to management are not corrected within a reasonable period of time.

Important defects: Failure to select and apply accounting policies in accordance with generally accepted accounting standards; for the process of preparing the financial report at the end of the period, if there are one or more defects in control and it is not reasonably able to ensure that the prepared financial statements achieve the objective of being true and accurate.

General defects: Other internal control defects that do do not meet the criteria for major defects or important defects.

2. Standards for identifying defects in internal control over non-financial reporting

(1) Quantitative standards for assessing defects in internal control over non-financial reporting determined by the Company are as follows:

Major defects: The overall impact level of the defect reaches 5% or more of the total profit.

Important defects: The overall impact level of the defect is between 3% (inclusive) and 5% of the total profit.

General defects: The overall impact level of the defect is less than 3% of the total profit.

(2) Qualitative standards for assessing defects in internal control over non-financial reporting determined by the Company are as follows:

Using the probability of economic losses resulting from the defect if no measures are taken as the judgment standard. When any of the following indications exist, the likelihood of a major defect increases; therefore, special attention is paid to the following situations: violation of national laws, regulations, or normative documents; major decision-making procedures being not scientific; important business areas lacking system controls or systemically failing; severe loss of core management personnel; the results of internal control assessments, especially that major or important defects cannot be rectified; other circumstances that have a material impact on the Company, etc.

Major defects: A major likelihood exists that this defect will cause economic losses and make it impossible to achieve business objectives.

Important defects: A likelihood exists that this defect will cause economic losses and make it impossible to achieve business objectives.

General defects: A low likelihood exists that this defect will cause economic losses and make it impossible to achieve business objectives.

(III) Identification of Internal Control Defects and Rectification

1. Identification of defects in internal control over financial reporting and rectification

Based on the above standards for identifying defects in internal control over financial reporting, during the reporting period, the Company had no major defects or important defects in internal control over financial reporting.

2. Identification of defects in internal control over non-financial reporting and rectification

Based on the above standards for identifying defects in internal control over non-financial reporting, during the reporting period, no major defects or important defects in the Company’s internal control over non-financial reporting were found.

IV. Explanations of Other Material Matters Related to Internal Control

During the reporting period, the Company has no other material matters related to internal control that require explanation.

Internal control is a dynamic process of operation and continuous improvement. The establishment and soundness of the internal control system should be aligned with the Company’s business scale, business scope, competitive situation, risk level, and so on, and should be adjusted in a timely manner as circumstances change. In 2025, based on changes in its business and in combination with the relevant national policies and regulations, the Company further supplemented and revised internal management systems, promoting the gradual optimization and improvement of the internal control system through dynamic management.

With changes in the Company’s scale, business scope, and internal and external environments such as national laws and regulations, the Company will continue to improve and enhance internal control systems, strengthen internal control supervision and inspections, and promote the Company’s healthy and sustainable development.

Jiuzhitang Co., Ltd. Board of Directors

March 27, 2026

Stock code: 000989 Stock abbreviation: Jiuzhitang Announcement No.: 2026-036

Jiuzhitang Co., Ltd.

Announcement on Convening the 2025 Annual Results Briefing Session

and Soliciting Questions

Our company and all members of the board of directors warrant that the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

Jiuzhitang Co., Ltd. (hereinafter referred to as the “Company”) has disclosed its 2025 annual report on March 27, 2026. To help investors better and more deeply understand the Company, the Company will hold an online 2025 annual results briefing session on April 9, 2026 (Thursday). The details are as follows:

I. Arrangements for the Results Briefing Session

1. Time: April 9, 2026 (Thursday) from 15:00 to 17:00 in the afternoon.

2. Meeting method: This results briefing session will be held via the internet. The Company and investors will conduct interactive Q&A through online text.

3. Participation method: Investors may participate through the Panoramic Web “Investor Relations Interactive Platform” (

4. Company participating personnel: Vice Chairman and General Manager Li Zhen’guo, independent director Zhang Jinsong, Chief Financial Officer Zhou Lubao, and Secretary to the Board Han Chenxiao.

II. Solicitation of Investor Questions and Methods

The Company is now soliciting relevant questions from investors in advance for the 2025 annual results briefing session. Investors are welcome to send related questions to the Company’s email address dshbgs@hnjzt.com in the form of an email before 17:00 on April 7, 2026 (Tuesday). The Company will answer questions that investors generally care about in the 2025 annual results briefing session. Investors are encouraged to actively participate.

Notice is hereby given.

Jiuzhitang Co., Ltd. Board of Directors

March 27, 2026

Stock code: 000989 Stock abbreviation: Jiuzhitang Announcement No.: 2026-037

Jiuzhitang Co., Ltd.

2025 Board of Directors’ Report

Our company and all members of the board of directors warrant that the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

I. Daily Work of the Board of Directors in 2025

In 2025, all members of the Company’s board of directors strictly complied with laws and regulations and regulatory requirements such as the 《Company Law》 and the 《Securities Law》, as well as relevant provisions such as the 《Articles of Association》, acted faithfully and with integrity, diligently and conscientiously performed their duties, carefully deliberated and scientifically decided, and completed the various work tasks of the board of directors in a relatively effective manner.

1. Meetings of the board of directors

During the reporting period, the Company’s board of directors held a total of 8 meetings, deliberating and passing 28 items of resolutions of various types. Decisions were made regarding the Company’s external investments, the 2024 annual report, the Company’s 2025 quarterly and semi-annual reports, etc. Each decision was prudent, scientific, and made promptly.

2. Execution of resolutions of the general meeting of shareholders

During the reporting period, convened by the Company’s board of directors in accordance with the relevant requirements, the Company held 4 general meetings of shareholders and formed 9 resolutions. The Company’s board of directors conscientiously implemented all resolutions of the general meetings of shareholders.

3. Information disclosure

During the reporting period, in accordance with relevant provisions, the Company disclosed a total of 83 periodic reports and various interim announcements. The contents include the Company’s periodic reports, interim announcements such as matters deliberated by the board of directors and the general meetings of shareholders, etc.

II. Directors’ Performance of Duties, Performance Evaluation Results, and Their Remuneration

(I) Directors’ fulfillment of their duty of loyalty

In 2025, all directors were able to promptly report related-party relationship situations and changes in related-party relationships in accordance with all relevant requirements. The directors’ current and concurrent positions/roles and their appointment in the Company do not involve any conflicts of interest. The directors did not use their positions and authority within the Company to seek personal benefits, did not use related-party relationships to harm the Company’s interests, did not accept improper benefits, did not disclose the Company’s secrets, or engage in any other conduct in violation of the duty of loyalty provisions under laws and regulations and the 《Articles of Association》.

(II) Directors’ fulfillment of their duty of diligence

In 2025, all directors performed their duties diligently and conscientiously. In executing their responsibilities, they took reasonable care typically expected of managers to serve the Company’s best interests, ensuring they had sufficient time and energy to carry out their duties. The board of directors held a total of 8 meetings during the year, and the directors’ attendance rate was 100%. Before each board meeting, all directors were able to carefully review the meeting materials sent by the Company, fully grasp the information, and during the meeting they were able to express professional opinions sufficiently regarding the items to be deliberated, and to propose suggestions on issues related to matters of key focus. They voted independently and objectively. During the intervals between board meetings, the directors maintained a high level of attention to all aspects of the Company’s operations and management.

(III) Directors’ self-performance capability

In 2025, directors were able to understand their own duties, strengthen their study of relevant laws, regulations, regulatory department rules, and economic conditions, and improve their own capability to perform their duties. They were able to strictly participate in board meetings and meetings of its special committees in accordance with relevant requirements, fully understand the responsibilities they shoulder, properly exercise the rights of directors, and also assume corresponding obligations.

(IV) Directors’ performance evaluation results

In 2025, the Company’s directors were able to strictly comply with all relevant requirements, fulfill their duties diligently and faithfully, safeguard the Company’s interests, and promote the Company’s fulfillment of social responsibilities. The evaluation results for the performance of directors’ duties in 2025 were all “good”.

(V) Directors’ remuneration (allowances) situation

The determination of the Company’s directors’ remuneration (allowances) is implemented in accordance with the relevant provisions of the proposal 《Principles for Remuneration (Allowances) of Directors, Supervisors and Senior Management Personnel》 approved by the Company’s general meeting of shareholders. The specific amounts are confirmed and disclosed in the corresponding chapters of the Company’s 2025 annual report.

III. Summary of the Company’s 2025 Work

In 2025, the Company closely followed the guiding philosophy of “driving innovation and breakthroughs to enhance vitality, expanding revenue and cutting costs to promote development,” focusing on its primary responsibilities and core businesses. Through further clarifying development paths and focusing on core values by deepening organizational structure adjustments and transforming the marketing system, and driven by market demand, it accelerated optimization of product structure and the deep development of channel potential. The progress of the stem cell project and the R&D of core products such as YB209 and YB211 met expectations, and innovative momentum continued to strengthen. It invested and held control in Jixianglong; strategic acquisitions landed in the polypeptide sector, extending the industrial chain and enhancing synergy value. Meanwhile, through efficient coordination of internal resources and further deepening lean management, it continuously improved production and operational efficiency, and achieved precise efforts in areas such as budget control, risk prevention, talent development, and brand building, thereby realizing coordinated improvements in sales, R&D, production, and management levels.

During the reporting period, the Company achieved operating revenue of 222,925.49 million yuan, representing a decrease of 5.99% compared with the same period last year; it achieved net profit attributable to shareholders of listed companies of 22,260.25 million yuan, representing an increase of 2.96% compared with the same period last year.

IV. Work Plan for the Company in 2026

In 2026, all of the Company’s work will closely focus on the targets set in the goal responsibility letters. Using budget management as a key tool, the Company will implement full-process dynamic monitoring. Once any deviation in budget execution is identified, it will promptly analyze and promptly correct it to ensure that issues are resolved within the budget framework. The assessment work will highlight重点 areas; strategies will be developed based on the characteristics of each operating segment, and resources will be focused on the core mission.

Jiuzhitang Co., Ltd. Board of Directors

March 27, 2026

Stock code: 000989 Stock abbreviation: Jiuzhitang Announcement No.: 2026-038

Jiuzhitang Co., Ltd.

Announcement on the Company’s Application to Banks

for Comprehensive Credit Facility Limits

Our company and all members of the board of directors warrant that the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

I. Overview of the Application for Comprehensive Credit Facility Limits

To meet the production and operating needs of the Company (including its subsidiaries), the Company plans to apply to banks for comprehensive credit facility limits not exceeding RMB 1.5 billion. The comprehensive credit facility includes, but is not limited to, working capital loans, bank acceptance bills, letters of guarantee, letters of credit, equity financing, and other comprehensive credit facility businesses. Within the scope of this credit limit, the Company (including its subsidiaries) will, according to actual needs, after fulfilling the corresponding approval procedures required by the Company (including its subsidiaries) and banks, choose and operate the various business product types. At the same time, the above comprehensive credit facility limit is the limit the Company (including its subsidiaries) plans to apply for from banks; the final determined amount shall be subject to the approved credit limit by the bank. The board of directors authorizes the Company’s management team to specifically implement the credit facility limits and report to the board of directors in a timely manner. The validity period shall be within 12 months from the date on which this board meeting is approved.

II. Approval Procedure

This matter was approved at the Company’s 13th meeting of the Ninth Board of Directors. According to the relevant provisions of the Shenzhen Stock Exchange and the 《Articles of Association》, this matter falls within the scope of authority of the board of directors and does not require submission to the general meeting of shareholders for deliberation.

III. Documents for Reference

Resolution of the 13th meeting of the Ninth Board of Directors

Jiuzhitang Co., Ltd. Board of Directors

March 27, 2026

Stock code: 000989 Stock abbreviation: Jiuzhitang Announcement No.: 2026-039

Jiuzhitang Co., Ltd.

Announcement on the 2026 Remuneration Plan for Directors

Our company and all members of the board of directors warrant that the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

On March 25, 2026, Jiuzhitang Co., Ltd. (hereinafter referred to as the “Company”) held the fifth meeting of the Ninth Board of Directors’ Nomination, Remuneration and Performance Evaluation Committee and the thirteenth meeting of the Ninth Board of Directors. The meetings deliberated and approved the proposal 《Proposal on the 2026 Remuneration Plan for Directors》. Since all directors abstained from voting on this proposal, the proposal was directly submitted to the Company’s 2025 annual general meeting of shareholders for deliberation. The specific plan is as follows:

To ensure that directors of Jiuzhitang Co., Ltd. (hereinafter referred to as the “Company” or “Jiuzhitang”) effectively fulfill their respective duties and obligations, to establish a compensation incentive and constraint mechanism with matching rights, responsibilities, and benefits, reasonably determine the performance evaluation criteria, remuneration levels, and payment methods for the Company’s directors, and in accordance with the 《Company Law of the People’s Republic of China》, the 《Corporate Governance Guidelines for Listed Companies》, and other relevant laws and regulations, as well as the 《Articles of Association》, this 2026 directors’ remuneration plan is formulated.

I. Applicable Parties

All directors of the Company, specifically divided into:

1. Internal non-independent directors: directors who have entered into employment contracts or service contracts with the Company or the Company’s controlling subsidiaries, including employees serving as directors;

2. External non-independent directors: non-independent directors who have not entered into employment contracts or service contracts with the Company or the Company’s controlling subsidiaries;

3. Independent directors: directors elected by the Company in accordance with the 《Measures for the Administration of Independent Directors of Listed Companies》 and the 《Articles of Association》, who have no relationship with the Company and its major shareholders that could potentially hinder their independent and objective judgment.

II. Principles

Directors’ remuneration should be consistent with market developments, matched with the Company’s operating performance and individual performance, and coordinated with the Company’s sustainable development.

The Company manages the budget for the total remuneration of directors. The total remuneration of directors for the current year uses the total remuneration of the previous year as the base, and is comprehensively determined in combination with factors such as the Company’s operating performance, the directors’ fulfillment of their duties, and the Company’s future development plans.

III. Applicable Period

January 1, 2026 to December 31, 2026

IV. Remuneration Standards

The Company determines the directors’ remuneration standards as follows based on directors’ identity, job nature, responsibilities, risks, pressure, etc.:

1. The remuneration of internal directors (including employees serving as directors) is their pre-tax income. They must pay various taxes and fees such as social insurance premiums and housing provident fund, personal income tax, etc., in accordance with regulations. The portion payable by individuals shall be withheld by the Company on behalf of the individual from the remuneration.

The remuneration of internal non-independent directors (including employees serving as directors) adopts an annual salary system. It is comprehensively determined based on the individual’s relevant work experience, the specific business areas they are assigned to manage within the Company, the market remuneration level for the corresponding position, the task and KPI targets undertaken, position responsibilities, and so on. It is divided into base remuneration and performance remuneration. Base remuneration is the fixed portion, while performance remuneration is the variable portion. Performance remuneration accounts for 60% of the total of base remuneration and performance remuneration.

Base remuneration is paid on a monthly average basis. Performance remuneration is calculated based on the Company’s operating conditions and the individual performance evaluation results. 60% of performance remuneration is paid in advance on a monthly basis. The remaining portion of performance remuneration is paid in a lump sum once after the annual report disclosure and completion of the performance evaluation, based on audited financial data. During the annual performance evaluation, the performance remuneration already paid in advance will be recalculated and confirmed according to the performance evaluation results. If any amount needs to be clawed back, the corresponding funds shall be clawed back according to the recalculation result. If there is any mid- to long-term incentive income (if any), it will be paid out according to the specific mid- to long-term incentive plan.

Internal non-independent directors (including employees serving as directors) who simultaneously serve as senior management personnel of the Company shall receive remuneration according to the remuneration standards stipulated in the Company’s 《Remuneration Plan for Senior Management Personnel for 2026》.

Internal non-independent directors (including employees serving as directors) who simultaneously serve in other positions that are not senior management personnel of the Company shall receive remuneration according to the remuneration management rules corresponding to their positions.

Internal non-independent directors (including employees serving as directors) do not receive any additional allowances due to serving as directors of the Company.

If internal non-independent directors (including employees serving as directors) also hold other positions in the Company and its subsidiaries at the same time, they shall not receive remuneration more than once.

2. Independent directors receive work allowances from the Company. The allowance standard for independent directors is RMB 120,000 per year (after tax), paid on a monthly basis, and no other remuneration shall be paid in addition.

3. External non-independent directors do not receive remuneration or allowances from the Company.

V. Organization and Management

The Company’s general meeting of shareholders is responsible for reviewing directors’ remuneration plans. The Nomination, Remuneration and Performance Evaluation Committee established under the board of directors serves as the Company’s remuneration and performance evaluation management body. It reviews the fulfillment of duties and conducts an annual performance evaluation for them.

VI. Other Provisions

For directors who leave their positions due to reasons such as board reshuffling, re-election, resignation during their term, etc., remuneration shall be paid according to their actual period of service and duty-fulfillment evaluation.

Jiuzhitang Co., Ltd. Board of Directors

March 27, 2026

Stock code: 000989 Stock abbreviation: Jiuzhitang Announcement No.: 2026-040

Jiuzhitang Co., Ltd.

Announcement of Resolutions of the Third Meeting

of the Ninth Board of Directors’ Independent Directors’ Special Meeting

Our company and all members of the board of directors warrant that the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

The notice of the third meeting of the Ninth Board of Directors’ independent directors’ special meeting of Jiuzhitang Co., Ltd. (hereinafter referred to as the “Company”) was sent on March 15, 2026 by email. The meeting was held on March 25, 2026 at the Company’s Management Center, First Meeting Room, in person. There should have been 3 independent directors attending; 3 independent directors attended in person.

All independent directors jointly nominated Ms. Zhang Jinsong to serve as the convener and chairperson for this meeting. The convening and holding of the meeting complies with relevant laws, regulations, rules and the 《Articles of Association》 and the 《Independent Directors’ System》. Before the meeting, the independent directors obtained and carefully reviewed the proposal contents. Based on the real, accurate, and complete materials obtained, and with an attitude of diligence and conscientiousness, and based on the principle of independent and objective judgment, all independent directors unanimously approved the following proposal:

Proposal on the Confirmation of Related-Party Transactions for 2025 in the Ordinary Course of Business and the Estimate of Related-Party Transactions for 2026 in the Ordinary Course of Business

The independent directors believe: The ordinary related-party transactions that occurred in 2025 and the ordinary related-party transactions expected to occur in 2026 fall within the Company’s normal operating needs, and are consistent with the Company’s actual situation. The transactions follow the principles of openness, fairness, and impartiality for market pricing, will not damage the interests of the Company and other non-related shareholders, especially small and medium-sized shareholders, and there is no situation where the Company’s main business forms reliance on related parties due to related-party transactions or is controlled by them. Therefore, we unanimously agree to the 《Proposal on the Confirmation of Related-Party Transactions for 2025 in the Ordinary Course of Business and the Estimate of Related-Party Transactions for 2026 in the Ordinary Course of Business》 and agree to submit the proposal to the thirteenth meeting of the Ninth Board of Directors for deliberation.

Voting situation: 3 votes in favor, 0 votes against, 0 abstentions. The proposal was approved.

Jiuzhitang Co., Ltd. Board of Directors

March 27, 2026

Stock code: 000989 Stock abbreviation: Jiuzhitang Announcement No.: 2026-042

Jiuzhitang Co., Ltd.

Special Explanation by the Board of Directors

on the Company’s Entrusted Wealth Management for 2025

Our company and all members of the board of directors warrant that the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

The Company’s board of directors has conducted a serious review of the Company’s entrusted wealth management for 2025. The relevant information is explained as follows:

1. Approval procedures for entrusted wealth management

The Company’s fifth meeting of the Ninth Board of Directors deliberated and approved the proposal 《Proposal on Authorizing the Use of Idle Own Funds for Entrusted Wealth Management》.

2. Purpose of entrusted wealth management: to improve the efficiency of using the Company’s idle own funds, reasonably use idle funds, and increase the Company’s investment returns.

3. Sources of funds for entrusted wealth management: the Company’s idle own funds.

4. Entrusted wealth management during the reporting period:

According to the board resolution, the Company (all of the following include subsidiaries) used funds with principal not exceeding RMB 1 billion for circular entrusted wealth management, and RMB 1 billion principal can be rolled over and reused.

Overview of entrusted wealth management during the reporting period (Unit: ten thousand yuan):

■

5. Internal control system implementation for entrusted wealth management during the reporting period

With a cautious approach, the Company invests in accordance with relevant requirements to prevent and control fund risks. During the reporting period, fund safety was ensured and it achieved relatively good investment returns.

6. Impact of entrusted wealth management on the Company

It has improved the efficiency of using the Company’s idle own funds, created certain investment returns for the Company, and did not affect the development of the Company’s main businesses.

Jiuzhitang Co., Ltd. Board of Directors

March 27, 2026

Endless information and precise interpretation—only on the Sina Finance app